M. Milanese (Pietra ligure (SV), Italy), F. Ricciardolo (Orbassano (TO), Italy)
Expiratory flow limitation in association to symptoms and quality of life in asthma, COPD and healthy subjects
A. Nasr (Lund, Sweden), G. Papapostolou (Lund, Sweden), K. Romberg (Höllviken, Sweden), L. Jarenbäck (Lund, Sweden), J. Ankerst (Lund, Sweden), A. Tunsäter (Lund, Sweden), L. Bjermer (Lund, Sweden), E. Tufvesson (Lund, Sweden)
|   |
Baseline characteristics associated with change in COPD symptoms over 2 years
A. Malinovschi (Uppsala, Sweden), C. Janson (Uppsala, Sweden), A. Palm (Uppsala, Sweden), M. Hårdstedt (Uppsala, Sweden), A. Farkhooy (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), K. Bröms (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), M. Högman (Uppsala, Sweden)
| |
The evaluation of patients’ life quality, spirometry parameters and level of exercise tolerance in case of asthma-COPD overlap and diabetes mellitus type 2 (DM2)
V. Halytska (Chernivtsi, Ukraine), G. Stupnytska (Chernivtsi, Ukraine), O. Fediv (Chernivtsi, Ukraine)
| |
Burden of disease in both asthma and COPD: one questionnaire?
L. Cuperus (Rotterdam, Netherlands), C. Van Zelst (Rotterdam, Netherlands), G. Braunstahl (Rotterdam, Netherlands), J. In 'T Veen (Rotterdam, Netherlands)
| |
Assessment of dyspnea in severe exacerbation of chronic obstructive pulmonary disease using the Multidimensional Dyspnea Profile (MDP)
A. Stump (Essen, Germany), U. Domanski (Essen, Germany), M. Schröder (Essen, Germany), G. Nilius (Essen, Germany)
| |
Evaluation of bronchial hyperreactivity in patients after Covid-19 infection
G. Strazda (Riga, Latvia), M. Ievina (Riga, Latvia), O. Madaja (Riga, Latvia), N. Jurka (Riga, Latvia), V. Gordjusina (Riga, Latvia), I. Taivans (Riga, Latvia)
| |
Functional capacity testing of citizens with COPD in limited settings - a feasibility study
J. Spence (Aarhus, Denmark), J. Brincks (Aarhus, Denmark), A. Løkke (Vejle, Denmark), L. Neustrup (Vejle, Denmark), E. Østergaard (Aarhus, Denmark), A. Løkke (Højbjerg, Denmark)
| |
Role of Asthma School in disease management
M. Zappa (Varese-Como, Italy), D. Visca (Tradate, Italy), P. Pignatti (Pavia, Italy), F. Ardesi (Varese-Como, Italy), R. Centis (Tradate, Italy), E. Zampogna (Tradate, Italy), F. Cherubino (Tradate, Italy), F. Oliva (Tradate, Italy), L. Saderi (Sassari, Italy), G. Sotgiu (Sassari, Italy), G. Migliori (Tradate, Italy), A. Spanevello (Tradate, Italy)
| |
Asthma Impairment and Risk Questionnaire (AIRQ) Performance in US Minority Patients
M. George (New York, NY, United States), D. Beuther (Denver, CO, United States), K. Murphy (Boys Town, NE, United States), R. Zeiger (San Diego and Pasadena, CA, United States), R. Wise (Baltimore, MD, United States), J. Reibman (New York, NY, United States), B. Chipps (Sacramento, CA, United States), I. Gilbert (Wilmington, DE, United States), J. Eudicone (Wilmington, DE, United States), H. Gandhi (Wilmington, DE, United States), K. Coyne (Bethesda, MD, United States), W. Mccann (Asheville, NC, United States)
| |
Prevalence of depression and anxiety among COPD patients and association with CAT Score:Findings from a lower-middle income country
M. Malik (Abbottabad, Pakistan), T. Ejaz (Karachi, Pakistan), M. Iqbal Malik (Rawalpindi, Pakistan), A. Raja (Rawalpindi, Pakistan)
| |
Clinical implication of DLCO to reflect disease control in patients with COPD
S. Yoon (Sejong-si, Republic of Korea), O. Kim (Sejong-si, Republic of Korea), J. Moon (Sejong-si, Republic of Korea)
| |
Anxiety-depressive syndrome in multi-hospitalized chronic obstructive pulmonary disease patients
K. DEGHDEGH (Annaba, Algeria), L. Belaid (Annaba, Algeria), B. Terra (Annaba, Algeria), R. Yakoubi (Annaba, Algeria), F. Atoui (Annaba, Algeria), R. Benali (Annaba, Algeria), F. Khalloufi (Annaba, Algeria)
| |
“Life-changing”- the experience of super-responders to biologics in severe asthma
J. Lanario (Plymouth, United Kingdom), L. Cartwright (Plymouth, United Kingdom), R. Jones (Plymouth, United Kingdom), R. Sayers (Exeter, United Kingdom), M. Hyland (Plymouth, United Kingdom), M. Masoli (Exeter, United Kingdom)
| |
Predictors of poor disease control and impaired quality of life (QOL) in patients with severe asthma (SA) in the Wessex Severe Asthma Cohort (WSAC)
V. Bataduwaarachchi (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), L. Wiffen (Portsmouth, United Kingdom), T. Jones (Portsmouth, United Kingdom), C. Barber (Southampton, United Kingdom), P. Howarth (Southampton, United Kingdom), C. Anoop (Portsmouth, United Kingdom)
| |
The usability of app-based spirometry tests for detection of exercise-induced bronchoconstriction in athletes
M. Isachsen (Stockholm, Sweden), T. Reier-Nilsen (Oslo, Norway), J. Stang (Oslo, Norway), H. Flatsetøy (Oslo, Norway), H. Ljungberg (Stockholm, Sweden), B. Nordlund (Stockholm, Sweden)
| |
The value of ventilation-perfusion scintigraphy in severe asthma control characterisation
D. Monteiro Canhoto (Coimbra, Portugal), G. Gonçalves (Coimbra, Portugal), C. Chaves Loureiro (Coimbra, Portugal)
| |
Identification of new spirometric indices predicting severe COPD
R. Kammoun (Sfax, Tunisia), S. Sallemi (Sfax, Tunisia), F. Elleuch (Sfax, Tunisia), S. Ben Jmeaa (Sfax, Tunisia), I. Kammoun (Sfax, Tunisia), K. Masmoudi (Sfax, Tunisia)
| |
Systematic literature review of the impact of asthma control on patient outcomes
A. Czira (Brentford, United Kingdom), X. Wang (Stockholm, Sweden), S. Singuru (Bangalore, India), C. Papagiannopoulos (Stockholm, Sweden), K. Rothnie (Brentford, United Kingdom), C. Trennery (Brentford, United Kingdom), S. Zhang (Collegeville, United States)
| |
Late Breaking Abstract - Real-world retrospective database analysis of COPD exacerbations before and during the COVID-19 pandemic in Europe (REACT)
D. Galkin (Cary, United States), A. Guasconi (Parma, Italy), J. Imperato (New York, United States), R. Hermans (London, United Kingdom), S. Pirondi (Parma, Italy), G. Georges (Cary, United States)
| |
Late Breaking Abstract - Health status relationship with exacerbations in a real-world cohort of patients with physician-assigned COPD in NOVELTY
H. Müllerová (Cambridge, United Kingdom), S. Franzén (Gothenburg, Sweden), L. Belton (Cambridge, United Kingdom), C. Erhard (Cambridge, United Kingdom), C. Nordon (Cambridge, United Kingdom), R. Hughes (Cambridge, United Kingdom), M. Sadatsafavi (Vancouver, Canada), C. Janson (Uppsala, Sweden)
| |